AMGN : Summary for Amgen Inc. - Yahoo Finance

U.S. Markets open in 5 hrs 1 mins

Amgen Inc. (AMGN)


NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
176.13+1.57 (+0.90%)
At close: 4:00PM EST

175.20 -0.93 (-0.53%)
Pre-Market: 4:02AM EST

People also watch
BIIBGILDCELGMRKBMY
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close174.56
Open174.21
Bid175.66 x 400
Ask176.67 x 100
Day's Range173.71 - 176.25
52 Week Range133.64 - 176.85
Volume2,445,217
Avg. Volume3,571,029
Market Cap129.71B
Beta1.67
PE Ratio (TTM)17.20
EPS (TTM)N/A
Earnings DateN/A
Dividend & Yield4.60 (2.64%)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Reuters10 hours ago

    Perrigo sells Tysabri royalty stream, delays annual report

    Drugmaker Perrigo Co Plc said on Monday it agreed to sell the royalty stream from its multiple sclerosis drug Tysabri to privately held Royalty Pharma for up to $2.85 billion. Perrigo said it would delay the filing of its annual report until March, and would review past accounting practices, specifically its historical revenue recognition of its Tysabri sales. The company also said its chief financial officer, Judy Brown, was stepping down, to be replaced by an interim finance head.

  • 3 Stocks You Don't Have to Babysit
    Motley Fool2 days ago

    3 Stocks You Don't Have to Babysit

    Amgen, Consolidated Edison, and Kinder Morgan are high-quality, low-stress stocks worth investing in for the long term.

  • AbbVie Stronger Bet Than Gilead, Amgen — At Least Until 2020: Leerink
    Investor's Business Daily4 days ago

    AbbVie Stronger Bet Than Gilead, Amgen — At Least Until 2020: Leerink

    AbbVie is a stronger stock bet than Gilead Sciences and Amgen, Leerink analyst Geoffrey Porges said Thursday.